Q9C0C2 (TB182_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 107.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: 182 kDa tankyrase-1-binding protein | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 1729 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Subunit structure | Binds to the ANK repeat domain of TNKS1 and TNKS2. |
| Subcellular location | Nucleus. Cytoplasm › cytoskeleton. Chromosome. Note: Colocalizes with chromosomes during mitosis, and in the cytoplasm with cortical actin. |
| Tissue specificity | Detected in testis, ovary, lung, skeletal muscle, heart, prostate and pancreas, and at very low levels in brain and peripheral blood leukocytes. |
| Post-translational modification | ADP-ribosylated by TNKS1 (in vitro). |
| Sequence caution | The sequence BAB21832.2 differs from that shown. Reason: Erroneous initiation. Translation N-terminally shortened. The sequence BAB84939.1 differs from that shown. Reason: Frameshift at positions 1070, 1098 and 1466. The sequence BAB84939.1 differs from that shown. Reason: Frameshift at positions 1071, 1097 and 1467. |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Chromosome Cytoplasm Cytoskeleton Nucleus |
| Coding sequence diversity | Alternative splicing Polymorphism |
| PTM | ADP-ribosylation Phosphoprotein |
| Technical term | Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Biological_process | nuclear-transcribed mRNA poly(A) tail shortening Traceable author statement. Source: Reactome telomere maintenance via telomeraseNon-traceable author statement Ref.1. Source: UniProtKB |
| Cellular_component | CCR4-NOT complex Inferred from direct assay PubMed 19558367. Source: UniProtKB cytoskeletonInferred from electronic annotation. Source: UniProtKB-SubCell cytosolTraceable author statement. Source: Reactome nuclear telomeric heterochromatinNon-traceable author statement Ref.1. Source: UniProtKB |
| Molecular_function | ankyrin binding Non-traceable author statement Ref.1. Source: UniProtKB enzyme bindingNon-traceable author statement Ref.1. Source: UniProtKB |
| Complete GO annotation... | |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q9C0C2-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q9C0C2-2) The sequence of this isoform differs from the canonical sequence as follows: 1-549: Missing. 1275-1327: GVGQADWTPD...RDLEVTCDPD → LGRHIYALCI...SSSSLPWVFF 1328-1729: Missing. | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 1729 | 1729 | 182 kDa tankyrase-1-binding protein | PRO_0000072437 | |||||
Regions | |||||||||
| Region | 210 – 1572 | 1363 | Acidic | ||||||
| Region | 1450 – 1542 | 93 | Tankyrase-binding | ||||||
| Motif | 1629 – 1635 | 7 | Nuclear localization signal Potential | ||||||
| Motif | 1723 – 1729 | 7 | Nuclear localization signal Potential | ||||||
| Compositional bias | 2 – 103 | 102 | Arg/Glu/Lys/Pro-rich (charged) | ||||||
| Compositional bias | 127 – 767 | 641 | Pro-rich | ||||||
| Compositional bias | 1010 – 1340 | 331 | Gly-rich | ||||||
| Compositional bias | 1572 – 1729 | 158 | Arg/Glu/Lys-rich (charged) | ||||||
Amino acid modifications | |||||||||
| Modified residue | 178 | 1 | Phosphoserine Ref.15 Ref.19 | ||||||
| Modified residue | 221 | 1 | Phosphoserine Ref.19 | ||||||
| Modified residue | 239 | 1 | Phosphothreonine Ref.15 | ||||||
| Modified residue | 429 | 1 | Phosphoserine Ref.15 Ref.18 Ref.19 Ref.21 | ||||||
| Modified residue | 435 | 1 | Phosphoserine Ref.15 Ref.19 | ||||||
| Modified residue | 437 | 1 | Phosphoserine Ref.19 | ||||||
| Modified residue | 494 | 1 | Phosphoserine Ref.15 Ref.18 | ||||||
| Modified residue | 498 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 601 | 1 | Phosphoserine Ref.14 Ref.15 Ref.19 Ref.21 | ||||||
| Modified residue | 672 | 1 | Phosphoserine Ref.9 Ref.15 Ref.19 Ref.21 | ||||||
| Modified residue | 691 | 1 | Phosphoserine Ref.10 Ref.14 Ref.17 Ref.18 Ref.19 Ref.21 | ||||||
| Modified residue | 695 | 1 | Phosphoserine Ref.10 | ||||||
| Modified residue | 712 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 744 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 762 | 1 | Phosphoserine Ref.15 Ref.19 | ||||||
| Modified residue | 833 | 1 | Phosphothreonine Ref.9 | ||||||
| Modified residue | 836 | 1 | Phosphoserine Ref.9 Ref.10 Ref.12 Ref.14 Ref.18 Ref.19 Ref.21 | ||||||
| Modified residue | 851 | 1 | Phosphoserine Ref.21 | ||||||
| Modified residue | 872 | 1 | Phosphoserine Ref.15 Ref.19 Ref.21 | ||||||
| Modified residue | 877 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 882 | 1 | Phosphoserine Ref.19 | ||||||
| Modified residue | 893 | 1 | Phosphoserine Ref.15 Ref.19 Ref.21 | ||||||
| Modified residue | 899 | 1 | Phosphoserine Ref.21 | ||||||
| Modified residue | 920 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 936 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 979 | 1 | Phosphothreonine Ref.15 | ||||||
| Modified residue | 983 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 987 | 1 | Phosphoserine Ref.15 Ref.19 | ||||||
| Modified residue | 1008 | 1 | Phosphoserine Ref.15 Ref.19 | ||||||
| Modified residue | 1024 | 1 | Phosphoserine Ref.19 | ||||||
| Modified residue | 1029 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 1054 | 1 | Phosphoserine Ref.21 | ||||||
| Modified residue | 1103 | 1 | Phosphoserine Ref.10 Ref.14 Ref.15 Ref.19 | ||||||
| Modified residue | 1133 | 1 | Phosphoserine Ref.15 Ref.19 | ||||||
| Modified residue | 1138 | 1 | Phosphoserine Ref.10 Ref.15 Ref.19 Ref.21 | ||||||
| Modified residue | 1178 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 1248 | 1 | Phosphoserine Ref.12 Ref.19 | ||||||
| Modified residue | 1253 | 1 | Phosphoserine Ref.19 | ||||||
| Modified residue | 1282 | 1 | Phosphothreonine Ref.19 | ||||||
| Modified residue | 1297 | 1 | Phosphoserine Ref.15 Ref.19 | ||||||
| Modified residue | 1328 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 1331 | 1 | Phosphoserine Ref.12 Ref.15 | ||||||
| Modified residue | 1383 | 1 | Phosphoserine Ref.9 Ref.19 | ||||||
| Modified residue | 1385 | 1 | Phosphoserine Ref.9 Ref.19 Ref.21 | ||||||
| Modified residue | 1439 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 1452 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 1533 | 1 | Phosphoserine Ref.15 Ref.19 Ref.21 | ||||||
| Modified residue | 1545 | 1 | Phosphoserine Ref.15 Ref.21 | ||||||
| Modified residue | 1558 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 1563 | 1 | Phosphothreonine Ref.15 | ||||||
| Modified residue | 1620 | 1 | Phosphoserine Ref.10 Ref.15 Ref.18 Ref.19 Ref.21 | ||||||
| Modified residue | 1621 | 1 | Phosphoserine Ref.10 Ref.15 Ref.18 Ref.19 Ref.21 | ||||||
| Modified residue | 1631 | 1 | Phosphoserine Ref.21 | ||||||
| Modified residue | 1652 | 1 | Phosphoserine Ref.15 Ref.19 | ||||||
| Modified residue | 1666 | 1 | Phosphoserine Ref.9 Ref.10 Ref.15 Ref.18 Ref.19 Ref.21 | ||||||
| Modified residue | 1715 | 1 | Phosphoserine Ref.19 | ||||||
Natural variations | |||||||||
| Alternative sequence | 1 – 549 | 549 | Missing in isoform 2. | VSP_026000 | |||||
| Alternative sequence | 1275 – 1327 | 53 | GVGQA…TCDPD → LGRHIYALCITLRTPPTPSL PWISSLVVEGFVPSSPPSLS LSASSSSLPWVFF in isoform 2. | VSP_026001 | |||||
| Alternative sequence | 1328 – 1729 | 402 | Missing in isoform 2. | VSP_026002 | |||||
| Natural variant | 322 | 1 | T → S. Ref.1 Corresponds to variant rs4939134 [ dbSNP | Ensembl ]. | VAR_028141 | |||||
| Natural variant | 714 | 1 | S → N. Corresponds to variant rs34203865 [ dbSNP | Ensembl ]. | VAR_032615 | |||||
Experimental info | |||||||||
| Sequence conflict | 84 | 1 | L → P in AAM15531. Ref.1 | ||||||
| Sequence conflict | 388 | 1 | P → S in AAM15531. Ref.1 | ||||||
| Sequence conflict | 554 | 1 | Q → H in BAB84939. Ref.7 | ||||||
| Sequence conflict | 604 | 1 | P → S in AAM15531. Ref.1 | ||||||
| Sequence conflict | 1450 | 1 | S → F in AAM15531. Ref.1 | ||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "The telomeric poly(ADP-ribose) polymerase, tankyrase 1, contains multiple binding sites for telomeric repeat binding factor 1 (TRF1) and a novel acceptor, 182-kDa tankyrase-binding protein (TAB182)." Seimiya H., Smith S. J. Biol. Chem. 277:14116-14126(2002) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT SER-322. Tissue: Placenta and Testis. |
| [2] | "Prediction of the coding sequences of unidentified human genes. XIX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro." Nagase T., Kikuno R., Hattori A., Kondo Y., Okumura K., Ohara O. DNA Res. 7:347-355(2000) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Brain. |
| [3] | "Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones." Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T. DNA Res. 9:99-106(2002) [PubMed] [Europe PMC] [Abstract] Cited for: SEQUENCE REVISION. |
| [4] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). Tissue: Hippocampus. |
| [5] | "Human chromosome 11 DNA sequence and analysis including novel gene identification." Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K., Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G. Sakaki Y.Nature 440:497-500(2006) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [7] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Skin. |
| [8] | "Characterization of long cDNA clones from human adult spleen. II. The complete sequences of 81 cDNA clones." Jikuya H., Takano J., Kikuno R., Hirosawa M., Nagase T., Nomura N., Ohara O. DNA Res. 10:49-57(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 495-1729 (ISOFORM 1). Tissue: Spleen. |
| [9] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-672; THR-833; SER-836; SER-1383; SER-1385 AND SER-1666, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [10] | "A probability-based approach for high-throughput protein phosphorylation analysis and site localization." Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P. Nat. Biotechnol. 24:1285-1292(2006) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-691; SER-695; SER-836; SER-1103; SER-1138; SER-1620; SER-1621 AND SER-1666, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [11] | "Toward a global characterization of the phosphoproteome in prostate cancer cells: identification of phosphoproteins in the LNCaP cell line." Giorgianni F., Zhao Y., Desiderio D.M., Beranova-Giorgianni S. Electrophoresis 28:2027-2034(2007) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Prostate cancer. |
| [12] | "ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage." Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J. Science 316:1160-1166(2007) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-836; SER-1248 AND SER-1331, MASS SPECTROMETRY. Tissue: Embryonic kidney. |
| [13] | "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis." Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III J. Proteome Res. 7:1346-1351(2008) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Cervix carcinoma. |
| [14] | "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle." Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M. Mol. Cell 31:438-448(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-601; SER-691; SER-836 AND SER-1103, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [15] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-178; THR-239; SER-429; SER-435; SER-494; SER-498; SER-601; SER-672; SER-712; SER-744; SER-762; SER-872; SER-877; SER-893; SER-920; SER-936; THR-979; SER-983; SER-987; SER-1008; SER-1029; SER-1103; SER-1133; SER-1138; SER-1178; SER-1297; SER-1328; SER-1331; SER-1439; SER-1533; SER-1545; SER-1558; THR-1563; SER-1620; SER-1621; SER-1652 AND SER-1666, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [16] | "Large-scale phosphoproteome analysis of human liver tissue by enrichment and fractionation of phosphopeptides with strong anion exchange chromatography." Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D., Zou H., Gu J. Proteomics 8:1346-1361(2008) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Liver. |
| [17] | "Large-scale proteomics analysis of the human kinome." Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G., Mann M., Daub H. Mol. Cell. Proteomics 8:1751-1764(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-691, MASS SPECTROMETRY. |
| [18] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-429; SER-494; SER-691; SER-836; SER-1620; SER-1621 AND SER-1666, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [19] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-178; SER-221; SER-429; SER-435; SER-437; SER-601; SER-672; SER-691; SER-762; SER-836; SER-872; SER-882; SER-893; SER-987; SER-1008; SER-1024; SER-1103; SER-1133; SER-1138; SER-1248; SER-1253; THR-1282; SER-1297; SER-1383; SER-1385; SER-1533; SER-1620; SER-1621; SER-1652; SER-1666 AND SER-1715, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [20] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [21] | "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation." Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B. Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-429; SER-601; SER-672; SER-691; SER-836; SER-851; SER-872; SER-893; SER-899; SER-1054; SER-1138; SER-1385; SER-1533; SER-1545; SER-1620; SER-1621; SER-1631 AND SER-1666, MASS SPECTROMETRY. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AF441771 mRNA. Translation: AAM15531.1. AB051528 mRNA. Translation: BAB21832.2. Different initiation. AK124903 mRNA. Translation: BAC85989.1. AP000781 Genomic DNA. No translation available. CH471076 Genomic DNA. Translation: EAW73731.1. BC023622 mRNA. Translation: AAH23622.1. BC150333 mRNA. Translation: AAI50334.1. AK074113 mRNA. Translation: BAB84939.1. Frameshift. |
| IPI | IPI00304589. IPI00847646. |
| RefSeq | NP_203754.2. NM_033396.2. |
| UniGene | Hs.530730. |
3D structure databases | |
| ProteinModelPortal | Q9C0C2. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | Q9C0C2. 7 interactions. |
| STRING | 9606.ENSP00000350990. |
PTM databases | |
| PhosphoSite | Q9C0C2. |
Polymorphism databases | |
| DMDM | 116242814. |
Proteomic databases | |
| PaxDb | Q9C0C2. |
| PRIDE | Q9C0C2. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000358252; ENSP00000350990; ENSG00000149115. ENST00000532437; ENSP00000437271; ENSG00000149115. |
| GeneID | 85456. |
| KEGG | hsa:85456. |
| UCSC | uc001njr.3. human. |
Organism-specific databases | |
| CTD | 85456. |
| GeneCards | GC11M057067. |
| HGNC | HGNC:19081. TNKS1BP1. |
| HPA | HPA037929. |
| MIM | 607104. gene. |
| neXtProt | NX_Q9C0C2. |
| PharmGKB | PA38789. |
| HUGE | Search... |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | NOG46995. |
| HOGENOM | HOG000001569. |
| HOVERGEN | HBG080593. |
| InParanoid | Q9C0C2. |
| OMA | RDSQGTY. |
| PhylomeDB | Q9C0C2. |
Enzyme and pathway databases | |
| Reactome | REACT_21257. Metabolism of RNA. REACT_71. Gene Expression. |
Gene expression databases | |
| ArrayExpress | Q9C0C2. |
| Bgee | Q9C0C2. |
| CleanEx | HS_TNKS1BP1. |
| Genevestigator | Q9C0C2. |
| GermOnline | ENSG00000149115. Homo sapiens. |
Family and domain databases | |
| ProtoNet | Search... |
Other | |
| ChiTaRS | TNKS1BP1. human. |
| GenomeRNAi | 85456. |
| NextBio | 76085. |
| SOURCE | Search... |
Entry information
| Entry name | TB182_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9C0C2 Secondary accession number(s): A7E2F8, Q6PJ35, Q6ZV74 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 11 Human chromosome 11: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |

Clusters with
